Cortisone acetate

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Synonym(s)

acetic cortex; CAS No: 50-04-4

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Half-lifeThis section has been translated automatically.

0,5–2 h

IndicationThis section has been translated automatically.

Substitution therapy for primary and secondary NNR insufficiency, severe allergic reactions, autoimmune diseases.

Limited indicationThis section has been translated automatically.

Children 6-12 years, pregnancy.

Dosage and method of useThis section has been translated automatically.

25-50 mg/day p.o.

Undesirable effectsThis section has been translated automatically.

InteractionsThis section has been translated automatically.

ContraindicationThis section has been translated automatically.

Gastrointestinal ulcers, severe osteoporosis, viral infections such as herpes simplex, herpes zoster (viral phase), varicella, systemic mycosis or protozoan infections, children < 6 LJ, glaucoma. S.a.u. systemic glucocorticoids.

PreparationsThis section has been translated automatically.

Cortisone CIBA

Authors

Last updated on: 29.10.2020